| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.78B | 22.75B | 21.13B | 20.38B | 18.70B | 18.92B |
| Gross Profit | 6.73B | 6.36B | 5.87B | 5.58B | 4.75B | 5.21B |
| EBITDA | 3.69B | 3.58B | 3.27B | 2.97B | 2.46B | 2.69B |
| Net Income | 2.32B | 2.15B | 2.09B | 1.87B | 1.51B | 1.72B |
Balance Sheet | ||||||
| Total Assets | 15.55B | 15.55B | 14.91B | 14.30B | 13.42B | 13.64B |
| Cash, Cash Equivalents and Short-Term Investments | 4.13B | 4.59B | 4.73B | 4.87B | 4.55B | 4.92B |
| Total Debt | 4.72B | 5.21B | 5.68B | 5.75B | 5.71B | 5.62B |
| Total Liabilities | 9.25B | 9.07B | 9.40B | 9.43B | 9.13B | 9.58B |
| Stockholders Equity | 6.30B | 6.48B | 5.51B | 4.87B | 4.29B | 4.06B |
Cash Flow | ||||||
| Free Cash Flow | 2.63B | 2.21B | 1.64B | 1.75B | 1.04B | 1.18B |
| Operating Cash Flow | 3.45B | 3.03B | 2.36B | 2.51B | 1.69B | 1.74B |
| Investing Cash Flow | -820.85M | -819.27M | -637.46M | -762.81M | -654.07M | -557.84M |
| Financing Cash Flow | -2.28B | -2.34B | -1.86B | -1.43B | -1.41B | -1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $73.90B | 31.73 | 38.42% | 0.90% | 11.86% | 13.46% | |
80 Outperform | $177.54B | 31.09 | 59.66% | 1.07% | 8.06% | 21.36% | |
76 Outperform | $6.10B | 13.21 | 17.64% | ― | 11.23% | 8.96% | |
68 Neutral | $19.96B | 32.59 | 29.06% | ― | 10.60% | 19.47% | |
67 Neutral | $7.76B | 8.23 | 26.47% | 2.45% | 1.58% | 11.13% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | $2.75B | 9.84 | 17.24% | 2.09% | 6.22% | 65.05% |